Arrayit Spokesperson Khrystyne Haje to Appear on Rachael Ray to Support Cancer Patients in Treatment


SUNNYVALE, Calif., March 21, 2012 (GLOBE NEWSWIRE) -- Initiating a broad outreach program, Arrayit Corporation (OTCQB:ARYC) announces that its spokesperson, Emmy Award winning actress and Civilian Medal of Honor recipient Khrystyne Haje, will appear on the Rachael Ray Show this Friday, March 23rd. Known for her starring role on ABC's "Head of the Class" and one of People magazine's "50 Most Beautiful People in the World", Khrystyne will have her hair cut on the show and donate it to Pantene's Beautiful Lengths program. Procter & Gamble's Pantene (NYSE:PG) and Hearst Corporation's Seventeen magazine are empowering patients undergoing cancer treatment by sponsoring the first ever National Donate Your Hair Day on April 27, with salons nationwide participating. The American Cancer Society will distribute the wigs through their network free of charge.

Rene Schena, CEO of Arrayit said, "Khrystyne's celebrity provides an excellent avenue for raising awareness about all aspects of cancer treatment, the importance of early diagnosis, and Arrayit's pipeline of tests."

Arrayit technology is based on microarrays, which are miniature devices that detect disease biomarkers in the blood stream years in advance of overt symptoms. The first in a pipeline of disease diagnostics and cancer screening tests, Arrayit's OvaDx® Pre-Symptomatic Ovarian Cancer Screening Test will be available to the public upon FDA approval through Arrayit Diagnostics, Inc.

About Arrayit Corporation

Arrayit leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies for disease prevention, treatment and cure.

- Powerful Science for Life™

Visit www.arrayit.com for more information.

Safe Harbor Statement

We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-KA for the fiscal year ended December 31, 2010 and Form 10-QA for the fiscal quarter ended September 30, 2011.


            

Contact Data